- PrimeView
- Published:
Psoriasis
Nature Reviews Disease Primers volume 2, Article number: 16083 (2016)
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1
Nature Communications Open Access 25 October 2023
Access options
Subscribe to this journal
Receive 1 digital issues and online access to articles
$119.00 per year
only $119.00 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Psoriasis is a chronic, immune-mediated disease characterized by cutaneous manifestations (often red, scaly plaques) and rheumatological complications (psoriatic arthritis). This PrimeView highlights the pathological mechanisms that lead to psoriatic lesions, in particular, the altered immune responses.
Rights and permissions
About this article
Cite this article
Psoriasis. Nat Rev Dis Primers 2, 16083 (2016). https://doi.org/10.1038/nrdp.2016.83
Published:
DOI: https://doi.org/10.1038/nrdp.2016.83